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ARTICLE
Zika virus enhances monocyte adhesion and
transmigration favoring viral dissemination
to neural cells
Nilda Vanesa Ayala-Nunez 1,2, Gautier Follain3, François Delalande4, Aurélie Hirschler4, Emma Partiot 1,
Gillian L. Hale5, Brigid C. Bollweg 5, Judith Roels6, Maxime Chazal 7, Florian Bakoa7, Margot Carocci8,
Sandrine Bourdoulous 9, Orestis Faklaris10, Sherif R. Zaki5, Anita Eckly 8, Béatrice Uring-Lambert11,
Frédéric Doussau 12, Sarah Cianferani4, Christine Carapito 4, Frank M.J. Jacobs6, Nolwenn Jouvenet 7,
Jacky G. Goetz 3 & Raphael Gaudin 1,2*
Zika virus (ZIKV) invades and persists in the central nervous system (CNS), causing severe
neurological diseases. However the virus journey, from the bloodstream to tissues through a
mature endothelium, remains unclear. Here, we show that ZIKV-infected monocytes repre-
sent suitable carriers for viral dissemination to the CNS using human primary monocytes,
cerebral organoids derived from embryonic stem cells, organotypic mouse cerebellar slices, a
xenotypic human-zebrafish model, and human fetus brain samples. We find that ZIKV-
exposed monocytes exhibit higher expression of adhesion molecules, and higher abilities to
attach onto the vessel wall and transmigrate across endothelia. This phenotype is associated
to enhanced monocyte-mediated ZIKV dissemination to neural cells. Together, our data show
that ZIKV manipulates the monocyte adhesive properties and enhances monocyte transmi-
gration and viral dissemination to neural cells. Monocyte transmigration may represent an
important mechanism required for viral tissue invasion and persistence that could be spe-
cifically targeted for therapeutic intervention.
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Zika virus (ZIKV) is a major public health concern world-wide1. Currently, no approved vaccine or drugs are avail-able for treatment. The virus is a blood-borne pathogen
from the Flaviviridae family that is transmitted through the bite
of an infected mosquito but also by human-to-human sexual
transmission, blood transfusion, and mother-to-child transfer
during pregnancy or at delivery. The most severe complications
include fetal microcephaly in pregnant women, Guillain–Barré
syndrome, as well as other neurological disorders not only in
fetuses, but also in newborns, infants, and adults, severe throm-
bocytopenia, and testicular damage and atrophy1–5. The wide
dissemination of the virus within the body suggests that mole-
cular and cellular mechanisms from the host are subverted to
allow ZIKV virions to travel from their port of entry toward
tissues. This is particularly important for the difficult-to-access
brain sanctuary. ZIKV efficiently invades and persists within the
brain6–8 and exhibits a preferential tropism for human neural
progenitor cells (hNPCs), which are key players in the develop-
ment of ZIKV-induced neurological diseases2,9–11. However, the
mechanism by which ZIKV travels toward and spreads into the
brain remains unknown.
Although endothelial blood-to-tissue permeability may allow
diffusive virus spreading in a first-trimester fetus, it is not clear
how ZIKV would invade hard-to-reach tissues exhibiting a
mature, impermeable endothelium. Yet, ZIKV efficiently reaches
and remains within the brain of hosts with a mature blood–brain
barrier (BBB)6,7,12–14. The BBB is an extremely tight endothelium
separating bloodstream-circulating virions from the neural target
cells. The Trojan Horse strategy, consisting of the infection of
circulating leukocytes that carry virus through endothelial
monolayers, has been proposed for numerous viruses in various
in vitro infection assays15–19, but never highlighted in an in vivo
context. Monocytes are considered as well-suited viral carriers
since they exhibit potent transmigrating abilities over endothelial
barriers, including the BBB20. It was recently shown that circu-
lating monocytes harbor ZIKV in vitro and in patients21–23, but
no further role was attributed to these cells in the physiopathol-
ogy of the infection.
Here, we show that ZIKV-infected monocyte-derived cells are
found in the CNS of a human fetus with microcephaly and we
assessed monocyte-driven ZIKV dissemination and damage in
ex vivo culture models, including human embryonic stem cell
(hESC)-derived cerebral organoids and organotypic mouse cere-
bellar slices. Moreover, we find that exposure of human mono-
cytes to ZIKV triggers higher expression of adhesion molecules,
higher capacities to spread and adhere to different substrates, and
higher abilities to attach and transmigrate through endothelia
in vitro and in a zebrafish embryo model as compared with
noninfected monocytes. Finally, we correlate the increased
transmigration phenotype to higher dissemination rates to hESC-
derived cerebral organoids compared with cell-free virus
infection.
Results
ZIKV-infected monocyte-derived cells found in a human fetus
CNS. First, we asked whether ZIKV-infected monocyte-derived
cells could be detected in human brain samples. Brain slices of a
ZIKV-positive human fetus (5 months) diagnosed with micro-
cephaly were stained for the viral protein NS1 together with the
leukocyte marker CD45, the monocytic marker CD14, or the
myeloid markers CD68 or CD163. Numerous cells expressing
these markers in the perivascular area were found positive for
ZIKV–NS1 (Fig. 1a–d and controls in Supplementary Fig. 1).
Importantly, although endothelial cells have been reported to be
targets of ZIKV in vitro24–26, we did not observe any infection of
these cells from the BBB of a naturally ZIKV-infected human
fetus with microcephaly (Fig. 1e).
Monocytes are productively infected by ZIKV. To assess for the
susceptibility of leukocytes to ZIKV infection, we isolated total
PBMCs from three human healthy donors infected in vitro by
ZIKV strains isolated in 2015 in Colombia (ZIKVC) and Panama
(ZIKVP) that share 99.5% similarity. Flow cytometry analysis was
performed to define the permissiveness of CD4+ T lymphocytes,
CD8+ T lymphocytes, B lymphocytes, monocytes, natural killer
(NK) cells, and NKT cells (Supplementary Fig. 2a). A primary
labeled anti-NS2B antibody that recognizes a nonstructural ZIKV
protein (that is not contained into incoming virions) was used to
identify cells supporting active ZIKV replication (as opposed to
noninfected cells carrying incoming particles). All cell types
showed some level of ZIKV infection, in a strain- and donor-
dependent manner (Supplementary Fig. 2a). Monocytes were the
most permissive cell type overall, in agreement with previous
reports21–23. Moreover, ZIKV induced a shift of the monocyte
population from a CD14+ CD16− toward a CD14+ CD16+,
preferentially infecting them (Supplementary Fig. 2b, c), which
correlates with studies that previously showed that the CD14+
CD16+ monocytic subset is particularly permissive to infection
by other Asian ZIKV strains21,22.
Given the variability observed among the three blood donors
examined, we then purified monocytes from PBMCs of these
three donors (donors A–C) as well as from four additional donors
(donors D–G). Flow cytometry analyses revealed that monocytes
were permissive to ZIKVC in six out of seven donors and to
ZIKVP in five out of seven donors (Fig. 2a). In the subsequent
experiments, we worked solely with the ZIKVC strain, which
shows better infectiveness, and will be referred to as ZIKV.
To determine whether the absence of NS2B staining in some
donors was due to low fluorescence sensitivity, we performed
reverse transcription quantitative polymerase chain reaction (RT-
qPCR) analysis on monocytes at different times post infection.
Successful replication was observed in two donors (Fig. 2b).
Specifically, the amount of viral RNA was first decreasing from 2
to 24 hpi, indicative of the expected incoming viral RNA
degradation, followed by an increase at 48 hpi. Such increase
represents viral replication. Thus, ZIKV replication in monocytes
is slow as compared with the 24-h cell cycle usually reported for
Flaviviruses in other cell types (see for instance ref. 27). This late
timing was also observed at the protein level, where NS2B was
successfully detected at 48 but not at 24 hpi (Supplementary
Fig. 3a). Detection of ZIKV RNA by fluorescence in situ
hybridization (FISH) in monocytes isolated from two donors
further demonstrated the ability of the virus to replicate in this
cell type (Fig. 2c). In agreement with flow cytometry and qPCR
data, very few cells were positive for viral RNA, suggesting that
only a small subset of monocytes is susceptible to infection.
Finally, productive monocyte infection was established by
measuring infectious viral particle release and we found that
monocytes shed a low amount of infectious ZIKV (Fig. 2d).
ZCL278, a Cdc42 inhibitor28 and a broad-spectrum virus entry
inhibitor29 abolished ZIKV infection of monocytes (Fig. 2d and
Supplementary Fig. 3b). In all the conditions tested, we measured
the amount of LDH released from dying cells as an indirect
measurement of cytotoxicity and found that neither ZIKV nor
ZCL278 induced cell death (Supplementary Fig. 3c).
ZIKV-infected monocytes disseminate the infection. As
monocytes are productively infected (Fig. 2), we then addressed
whether they could disseminate ZIKV to target cells. Therefore,
we grew cerebral organoids from hESCs30,31 to use them as a 3D
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model of neurological tissue (see Supplementary Fig. 4a and
Materials and Methods for details). At 3 weeks post differentia-
tion (wpd), the cells composing the cerebral organoids were
mostly Pax6-positive, indicative of neural precursor cells (Sup-
plementary Fig. 4b). At 5 wpd, the organoids contained Pax6-
positive cells organized as Rosetta and a high number of term-
inally differentiated neurons, as shown by the increased number
of CTIP2-positive cells (Supplementary Fig. 4c). The hESC-
derived cerebral organoids were cocultured with cell-free ZIKV or
ZIKV-infected monocytes for 2 days, and analyzed by flow
cytometry to measure the percentage of live ZIKV-infected cells
among the CCR2-negative population (to exclude the mono-
cytes). Strikingly, we observed that ZIKV-infected monocytes
isolated from two donors were successful at disseminating the
infection to the organoids as early as 2 days post contact, while
the ability of cell-free virus to disseminate the infection was
marginal to null (Fig. 3a, b and Supplementary Fig. 4d). When the
infection was allowed for 9 days, the organoids infected with cell-
free virus were successfully infected as well (Supplementary
Fig. 4e–f), suggesting that monocytes accelerate the kinetics of
ZIKV dissemination to cerebral organoids.
ZIKV-infected monocytes alter the cytoarchitecture of the
cerebellum. To further explore the functional relevance of the
presence of infected monocytes in the CNS, we used an orga-
notypic culture of mouse cerebellar slices32, a method of choice
for the ex vivo study of viral infection. ZIKV was shown to induce
abnormal cerebellum anatomy in mice33, and thus organotypic
culture provides a tissue that maintains cellular composition,
tissue architecture, and function of a bona fide cerebellum32. The
cerebellar slices were incubated for 4 days with noninfected
human monocytes, ZIKV-infected monocytes, or cell-free virus in
the presence or absence of ZCL278 (scheme in Fig. 3c). Staining
of the Purkinje cell layer and nuclei showed relatively well-
conserved tissue architecture in untreated conditions (Fig. 3d).
Quantification of the proportion of altered, intermediate, or
healthy lobules highlighted that the cerebellar slices incubated
with ZIKV-infected monocytes represent the only condition in
which altered cytoarchitecture of the cerebellar lobules was sig-
nificantly increased (Fig. 3e), suggesting that cell-associated viral
dissemination favors neuropathogenesis. This phenotype was
completely reversed by the use of the antiviral ZCL278.
ZIKV-infected monocytes exhibit higher transmigration abil-
ities. To test whether ZIKV could influence circulating mono-
cytes to cross the BBB, transwell inserts were seeded with the
human cerebellar microvascular endothelial cell D3 (hCMEC/
D3)34 (see scheme Fig. 4a). Under our culturing conditions,
hCMEC/D3 cells form a tight monolayer exhibiting robust
impermeability (Supplementary Fig. 5a–b), within the range of
expected tightness35. ZIKV-infected monocytes, cell-free virus,
and ZCL278 treatment did not significantly perturb endothelial
impermeability (Supplementary Fig. 5c). No viral replication was
observed in the hCMEC/D3 monolayer during the course of the
experiment (Fig. 4b). However, a significantly greater percentage
of monocytes that transmigrated were ZIKV-positive (bottom
chamber, green) compared with the one that did not transmi-
grate (top chamber, red; Fig. 4c). Consistently, scanning confocal
microscopy analysis revealed that a greater proportion of
monocytes were found under the endothelial monolayer when
exposed to ZIKV (Fig. 4d, e).
Together, our data indicate that ZIKV readily enhances the
ability of monocytes to transmigrate, while the permeability of the
endothelial layer remains unaffected.
ZIKV-exposed monocytes exhibit higher adhesion properties.
To further investigate the impact of ZIKV on human primary
monocytes, we performed differential quantitative proteome
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Fig. 1Monocyte-derived cells are infected by ZIKV in a human fetus with microcephaly. a–e Immunohistochemical staining was performed on human fetal
brain tissues from a PCR-confirmed case of congenital ZIKV (gestational age 22 weeks). All slides were counterstained in Mayer’s Hematoxylin and blued
in Lithium carbonate. The tissue slices were stained for ZIKV–NS1 in combination with a CD45 (left panel: 63×, right panel: 40×), b CD14 (20×), c CD68
(upper panel: 63×, lower left panel: 100×, and lower right panel: 40×), or d CD163 (upper panel: 40×, lower left panel: 100×, and lower right panel: 63×).
e The endothelial cells of slices from the same tissue appear morphologically intact and were never found positive for ZIKV–NS1 staining. The black
arrowheads indicate ZIKV-infected cells. BV blood vessel
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profiling by using highly sensitive and robust liquid chromato-
graphy coupled to tandem mass spectrometry (LC–MS/MS). A
total of 545 proteins were differentially expressed (198 upregu-
lated and 347 downregulated) between mock and ZIKV-exposed
monocytes from two donors (in quadruplicates, FDR 0.05; see
Supplementary Data 1). Upon parallel analyses by using
STRING36 (highest confidence 0.9) and GSEA37 (“biological
process” and “cellular component” pathways), we observed that
ZIKV induced a significant enrichment of proteins associated
with adhesion, vesicular transport (clathrin-mediated endocytosis
and cytoskeleton-related proteins), and RNA processing and
translation (Fig. 5a, b). Specifically, integrins (β1, α5, and αM),
ICAM3, PECAM1, IQGAP1, catenin, myosins, actinin, KIF5B,
vinculin, talin, and filamin A and B that are involved in cell
adhesion and/or in the establishment of focal adhesion sites, were
upregulated by ZIKV (Supplementary Data 1). Proteins asso-
ciated with the immune system response were not significantly
upregulated in monocytes upon ZIKV infection. By comparison,
monocytes exposed to HIV-1, which is unrelated to flaviviruses,
or to the closely related Dengue 2 virus (DENV2), elicited an
enrichment of proteins involved in antiviral immune response,
but no modulation of adhesion-related proteins (Supplementary
Fig. 6). Thus, the increase in expression of adhesion proteins in
monocytes seems specific for ZIKV infection.
To determine whether the ZIKV-induced expression of
adhesion molecules was overrepresented at their functional
location, i.e., the cell surface, we next assessed by flow cytometry
the monocyte’s surface expression levels of a panel of well-known
adhesion molecules. We found that 10 out of the 22 proteins
tested were significantly upregulated at the surface of monocytes
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Fig. 2 Human primary monocytes are productively infected by ZIKV. aMonocytes purified from seven healthy blood donors were infected with Colombian
(ZIKVC) or Panama (ZIKVP) ZIKV strains at MOI 1 (+) or 5 (++) for 48 h. Cells were fixed, permeabilized, and processed for flow cytometry. The
percentage of ZIKV-infected cells (NS2B+) is plotted as a function of the strain and amount of ZIKV used. Each dot corresponds to the mean ± SD of ZIKV-
infected cells for each donor and each condition in two individual samples. b Monocytes were infected for the indicated time with ZIKV (MOI 1) for 48 h.
Total RNA was extracted and RT-qPCR was performed by using ZIKV and GAPDH-specific primers. The graph represents the fold change of ZIKV RNA
with respect to GAPDH of a triplicate ± SD. Data from two donors are shown. No ZIKV RNA was detected in monocytes from a third donor in this
experiment (data provided in the Source Data file). c Monocytes infected with ZIKV for 48 h were fixed and fluorescence in situ hybridization (FISH) was
performed by using a ZIKV-specific RNA probe (magenta) and nuclei were stained with NucBlue (blue). Left and right panels are representative images
from experiments done with two donors. Scale bar: 5 µm. dMonocytes purified from four healthy donors were untreated or pretreated with 50 µM ZCL278
for 30min at 37 °C. The cells were then infected with ZIKV (MOI 1) in the presence or absence of ZCL278. The inoculum was removed at 4 h post
infection, after which the cells were washed and re-incubated in complete media for 48 h. The supernatant was harvested and a plaque assay on Vero cells
was performed to titrate ZIKV production. The bar graphs represent the mean+ SD of two independent samples. Each dot represents the mean of a
duplicate. ZCL278 treatment inhibited ZIKV infection of monocytes by 93% (±7). The letters attributed to each donor correlate with the ones in a. The
two-tailed p value was <0.05 (*). Statistical significance was determined by using a t test. NI noninfected. Source data in a–d are provided as a Source
Data file
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from three donors (Fig. 5c). Interestingly, productive infection
was not strictly required as noninfected bystander cells (Fig. 5d),
and UV-inactivated ZIKV (Fig. 5e and Supplementary Fig. 7) also
significantly induced the overexpression of the adhesion-
associated protein CD99. Of note, UV-inactivated virus exposure
induced an early overexpression of CD99 at the surface of
monocytes (Fig. 5e) and therefore, the molecular mechanism
behind this increase could differ from the one observed in ZIKV-
infected monocytes. Interestingly, while CD99 and ITGAL were
significantly overexpressed at the cell surface of monocytes
(Fig. 5c–e), we observed a decreased expression of the mRNA
coding for these proteins (Supplementary Fig. 8). As ZIKV
enhances RNA processing and translation-related proteins
(Fig. 5a, b), one could hypothesize that ZIKV lowers transcription
levels and favors translation by an unknown mechanism.
We next investigated whether the observed ZIKV-induced
adhesion phenotype would have a functional role on monocyte’s
attachment. Upon ZIKV infection, adhesion of monocytes was
significantly increased on different substrates and on hCMEC/D3
endothelial cells (Fig. 5f–h). This increased attachment was
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Fig. 3 ZIKV-infected monocytes promote viral dissemination and tissue damage to cerebral organoids. a, b Cerebral organoids of 3 or 5 weeks post
differentiation (wpd) were cocultured with ZIKV-infected monocytes, noninfected monocytes, cell-free ZIKV, or mock for 2 days. The organoids were then
fixed and processed for a immunofluorescence or b flow cytometry. a A slice and the 3D view of the same organoid are shown, which was cocultured with
ZIKV-infected monocytes. The crop shows infected cells (not monocytes) in yellow. Scale bar: 50 µm. b The bar graphs represent the mean of an
experiment performed in duplicate ± SD with monocytes from two donors. c–e Organotypic cultures of mouse cerebellar slices were cultured in the
presence or absence of cell-free ZIKV or ZIKV-infected monocytes ± ZCL278. c Experimental design. d A staining with an anti-calbindin antibody (green)
and Dapi (blue) was done to observe the tissue cytoarchitecture. Scale bar: 500 µm. e The cytoarchitecture index is a measurement of the degree of tissue
injury. Three categories were defined: healthy (part of the lobule with a regular alignment of Purkinje), intermediate (partially damaged, sparse Purkinje), or
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specific for ZIKV, since infection with HIV-1 and treatment with
hGM-CSF did not result in such an increase (Fig. 5f).
ZIKV-exposed monocytes exhibit increased spread-out mor-
phology. From the imaging in Fig. 5g and 3D reconstructions in
Fig. 6a, we noticed that exposure to ZIKV correlated with an
extended spread morphology of the monocytes. Quantification of
the cell’s area and circularity upon attachment to endothelial cells
in ZIKV-exposed monocytes confirmed that ZIKV induces a
dramatic spread-out morphology compared with naive mono-
cytes (Fig. 6b, c and Supplementary Fig. 9).
Given the importance of Cdc42 on integrin-mediated cell
adhesion, spreading, and transmigration38,39, we tested the small
molecule ZCL278, in which activity was initially reported to
suppress Cdc42-dependent cell motility28, as an inhibitor of
ZIKV-induced transmigration. Remarkably, ZCL278, when added
post infection, selectively prevented transmigration of monocytes
exposed to ZIKV (Fig. 6d), while noninfected cells were
insensitive to the drug.
Together, our data show that ZIKV induces higher adhesion,
spreading, and transmigration of human primary monocytes
across an in vitro BBB-like model.
ZIKV-exposed monocytes exhibit higher transmigration
properties in vivo. We next aimed at demonstrating the rele-
vance of this phenotype in vivo. Since transmigration is a very
challenging process to study in mammals, we tested whether
zebrafish embryos could represent a suitable alternative. To this
end, we developed a novel quantitative xenotypic system based on
a procedure designed to dissect the early behavior of circulating
cells in the zebrafish embryo bloodstream40,41. Monocytes were
infected with ZIKV alone or ZIKV in the presence of a pan-
flavivirus antibody known to increase infection through antibody-
dependent enhancement (ADE)42,43 (Supplementary Fig. 10).
Transgenic zebrafish embryos Tg(fli:EGFP) modified to express
EGFP in endothelial cells44 were injected with prelabeled human
primary monocytes (see Fig. 7a, b, Supplementary Movie 1, and
Materials and Methods for details) and imaged ≈6 h post injec-
tion, a timing sufficient to observe the monocytes inside, outside,
and transmigrating through the vasculature (Fig. 7c). Mapping
the location of the monocytes that successfully transmigrated out
of the vascular caudal plexus did not show significant differences
between the different conditions (Fig. 7d). However, the per-
centage of extravasated cells was significantly increased when
monocytes were previously exposed to ZIKV for all three donors
tested (Fig. 7e). Transmigration efficiency was not linked to the
percentage of ZIKV-infected cells as ADE–ZIKV had no sig-
nificant further effect on monocyte transmigration compared
with monocytes infected in the absence of ADE.
ZIKV-exposed monocytes exhibit higher arresting properties
in vivo. To further determine the mechanism by which ZIKV
promotes monocyte transmigration in vivo, we defined the
hemodynamic behavior of circulating human monocytes in the
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bloodstream of zebrafish embryos upon injection. Three main
dynamic phenotypes could be monitored: circulating, stopping,
and rolling-like motion (Fig. 8a and Supplementary Movie 2).
Automated tracking of circulating monocytes revealed that pre-
vious exposure to ZIKV significantly increased monocyte track
duration (Fig. 8b). In parallel, the speed of ZIKV-exposed
monocytes was drastically diminished (Fig. 8c–e). These mea-
surements correlated with a greater percentage of ZIKV-exposed
monocytes immobilized onto the endothelial vasculature com-
pared with monocytes that were not in contact with the virus
(Fig. 8f). However, once immobilized on the vessel wall, the
average time of monocyte arrest was independent of the infection
status of the cell (Fig. 8g). Of note, enhancing ZIKV infection of
monocytes through ADE did not potentiate these behaviors.
These data suggest that exposure to ZIKV promotes the initial
attachment of human primary monocytes to the endothelial cell
wall without impacting their arrest duration.
Transmigrated monocytes disseminate ZIKV to cerebral
organoids. We then intended to directly link monocyte trans-
migration to viral dissemination and CNS neuroinvasion. We
thus established a coculture transmigration assay, in which
transwells coated with an endothelial monolayer of hBMEC/D3
cells, were incubated with cell-free ZIKV or ZIKV-associated
monocytes in the top chamber, and with 6-wpd cerebral orga-
noids in the bottom chamber (scheme Fig. 9a). In this setting, and
in the absence of chemokine addition in the organoid-containing
bottom chamber, we observed that the proportion of monocytes
that transmigrated was higher when exposed to ZIKV than in the
absence of virus (Supplementary Fig. 11a), consistent with our
previous observations indicating that ZIKV enhances monocyte
transmigration (Fig. 4). The transwell inserts were removed at the
end of the overnight transmigration process, at a time that did not
allow infection of endothelial cells (Fig. 4c), and the cerebral
organoids were collected 48 h later. Flow cytometry analysis of
the dissociated organoids revealed that the cerebral cells were
more permissive to infection driven by ZIKV-infected monocytes
than by cell-free virus (Fig. 9b, c). Nevertheless, at 9 dpi, no
difference in the percentage of cerebral-infected cells was
observed (Supplementary Fig. 11b), suggesting that cell-free virus
can cross the endothelium in the absence of leukocyte carriers,
but with delayed viral dissemination.
Together, these data indicate that ZIKV-induced monocyte
transmigration promotes viral dissemination across the
vessel wall.
Discussion
In this study, we propose a model in which ZIKV productively
infects a subset of blood-circulating monocytes and induces
phenotypical and morphological changes, which in turn leads to
higher monocyte adhesion and transmigration abilities. Upon
transmigration, monocyte-associated ZIKV shows faster
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infectiveness kinetics toward reconstituted mini-brains than cell-
free virus.
We have shown that cells derived from circulating monocytes
are host targets in the brain of a ZIKV-infected human fetus.
Resident perivascular macrophages (CD163+) and microglia
(CD68+) originate from the embryonic yolk sac or from blood-
circulating monocytes that differentiate upon transmigration45,46.
The importance of the recruitment of circulating monocytes to
the CNS during the course of an infection by West Nile Virus
(WNV), a ZIKV-related Flavivirus, was previously demonstrated
in mice47. This study indicates that the infiltrated myeloid cells in
the CNS originate from blood-circulating monocytes. A recent
study showed that the recombinant NS1 protein of several Fla-
viviruses induces transient endothelial permeability48. This work
highlighted the presence of vascular leakage in mice injected with
recombinant NS1, but further in vivo studies by using ZIKV
infection models that recapitulate the physiopathology of a nat-
ural infection in humans will be required. Negligible BBB dis-
ruption was found in WNV-infected mice with encephalitis47 and
our in vitro data failed to detect endothelial permeability fol-
lowing ZIKV exposure (Fig. 4b), similarly to previously published
data26. Moreover, ZIKV is mostly asymptomatic in humans and
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does not induce hemorrhagic fever or cytokine storm4,49, sug-
gesting that endothelial leakage may not be a major feature of
ZIKV physiopathology.
Endothelial cells have also been reported to be targets of ZIKV
in vitro24–26 by using different viral strains and/or cell lines.
However, we did not observe infection or disruption of endo-
thelial cells from the BBB of a naturally ZIKV-infected human
fetus with microcephaly (Fig. 1e) and in our experimental design,
hCMEC/D3 cells were not infected by ZIKV (Fig. 4c). Thus, the
virus’ main access to the CNS remains to be further characterized
as several models, including endothelial cell infection, the Trojan
horse hypothesis, and transient BBB permeability remain plau-
sible and not mutually exclusive. Further work will also be
required to assess whether ZIKV could subvert other pathways,
such as transcytosis, to cross the BBB.
We and others have observed that ZIKV does not induce a
robust immune response in monocytes (our proteomics data in
Fig. 5a, b and refs. 50–52), in sharp contrast to DENV2 and HIV-
153,54. It could be explained by the capacity of the NS5 protein of
ZIKV to suppress interferon signaling55. However, ZIKV infec-
tion is not fully immunologically silent in all cell types and higher
production of MCP-1, a monocyte chemoattractant, in mice and
macaques has also been reported56,57. Moreover, the work by
O’Connors et al. established that monocytes are targeted by the
virus in macaques and that these cells are recruited to tissues,
promoting viral persistence56. Therefore, ZIKV-infected mono-
cytes could represent a bona fide Trojan Horse-like carrier used
by ZIKV to cunningly disseminate into the CNS. Therefore,
monocytes may represent an important systemic mediator of
tissue invasion and viral persistence, and additional in vivo stu-
dies will help to evaluate the relative contribution of monocytes in
the ZIKV neuroinvasion process.
ZIKV enhances monocyte adhesion and transmigration
through the vessel wall, inducing higher expression of adhesion
molecules at the monocyte surface (Fig. 4). This mechanism of
action is specific to ZIKV as we did not observe the adhesion-
related pathway upregulation in HIV-1 and DENV2 infection of
monocytes. HIV-1 also enhances transmigration to the CNS58,
but the underlying molecular mechanism likely differs from the
one of ZIKV, as HIV-infected monocytes do not adhere sig-
nificantly more than control cells (Fig. 5f–h). Dengue virus does
not trigger transmigration of J774 monocytic cells59, further
highlighting the specificity of ZIKV–monocyte interactions that
we reported here. The impact of ZIKV-infected monocytes on the
adhesion molecule profile of endothelial cells would also be
relevant to address in future work, as monocyte–endothelial
communication plays an important role in adhesion60.
Transmigration induced by ZIKV was prevented by treating
cells with an inhibitor of Cdc42 function (Fig. 6d). A previous
report pointed out that Cdc42 was not required for physiological
monocyte adhesion and spreading61, and thus, ZIKV could
engage a Cdc42-dependent actin remodeling program that is not
usually implicated in physiological monocyte transmigration.
This observation may have important implications for the design
of treatments with selective activity. The dual action of ZCL278 as
a Cdc42 inhibitor and as a potent antiviral molecule may be a
promising antiviral option that requires further investigations.
Live-cell imaging of leukocyte circulation, arrest, rolling, and
transmigration is very challenging to perform in complex mam-
mals, such as in mice. The technical limitations include body
hindrance under the microscope, heartbeat-repetitive pulses, lack
of organ transparency, and loss of the injected cells into body
parts that are not accessible to imaging. Although powerful 3D
organoid models that mimic blood vessels are being developed62,
they represent in vitro systems that do not fully recapitulate the
complexity of a living organism. In this context, the zebrafish
embryo represents a promising in vivo alternative, previously
used to study mammalian viruses63–65. Indeed, the zebrafish
embryo is relatively transparent, easy to handle, and displays fast
growth kinetics, and numerous tools for genetic manipulation are
available. Moreover, the zebrafish embryo represents a classical
approach to study cancer cell extravasation66,67, but has never
been employed, to our knowledge, to study virus-induced trans-
migration. Here, we have developed a xenotypic system, injecting
human primary monocytes into zebrafish embryos (Figs. 7 and 8).
We showed that human primary cells retained their capacity
to undergo diapedesis through a zebrafish endothelial barrier,
suggesting that active molecular interactions between these cells
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are taking place despite the species’ gap. This experimental in vivo
model was recently exploited to perform extensive human
monocyte phenotyping upon injection in zebrafish68. The
development of this robust and easy-to-manipulate in vivo model
allowed quantitative analyses of monocyte transmigration under
hemodynamically relevant conditions that would not have been
achieved with other animal models.
The cerebral organoid model derived from hESCs was pre-
viously characterized and used in the context of ZIKV infection69
as these organoids recapitulate much of the architecture of the
fetal brain, modeling whole-brain development70. A limitation
however is that cerebral organoids do not spontaneously develop
a functional vasculature (unless transplanted71), and we thus had
to engineer a transwell-organoid system to allow the combined
investigations of both transmigration and dissemination (Fig. 9).
In this system, we found that cell-free virus had slower kinetics of
dissemination than monocyte-associated virus, suggesting that
monocytes could accelerate viral spreading toward tissues.
In conclusion, by using various in vitro, ex vivo, and in vivo
models, we have shown that ZIKV enhances monocyte transmi-
gration to efficiently cross endothelial barriers and promotes viral
dissemination. Our findings are of importance in regard to our
current understanding of ZIKV–host interactions and highlight
monocyte transmigration as a process that could be specifically
targeted for therapeutic intervention.
Methods
Cell culture. Purified human primary monocytes were cultured in RPMI 1640
(Gibco) supplemented with 2% FBS (Dutscher) and 1% Penicillin–Streptomycin
(Gibco). Cells were cultured into round-bottom tissue culture-treated 96-well
plates. The human Cerebellar Microvascular Endothelial Cells D3 (hCMEC/D3)
cells34 (provided by S. Bourdoulous, Institut Cochin, France) were cultured by
using EndoGRO‐MV Complete Culture Media (Millipore) supplemented with
1 ng/mL bFGF (Sigma) and 1% Penicillin–Streptomycin (Gibco). Cells were plated
and cultured in dishes coated with rat collagen-I (R&D Systems). Lithium Chloride
(10 mM) and Resveratrol (10 μM) were added when seeding the cells in the culture
inserts (cf. transmigration assay). Vero cells (ATCC, CCL-81) were cultivated in
High-glucose DMEM media with L-Glutamine (Hyclone), 10% FBS, and 1%
Penicillin–Streptomycin. All cell types were maintained at 37 °C in a humidified
atmosphere containing 5% CO2.
Human primary monocytes. The buffy coats were obtained from healthy blood
donors (EFS Strasbourg, France). All donors signed informed consent allowing the
use of their blood for research purposes. PBMCs were purified on a Ficoll density
gradient (GE Healthcare). Monocytes were isolated by positive selection by using
CD14+ microbeads and magnetic columns from Miltenyi Biotec. Monocytes were
derived from a total of 22 individual blood donors. For experiments shown in
Figs. 3b, 4b, c, 5f, h, 6d, and 9c, donors were randomly chosen and cannot be
compared between experiments. The source data underlying these figures are
referred to “datasets” in the Source Data file. For experiments shown in Figs. 2a, b,
d, and 7e, the same donors were used and are labeled by letters (A, B, C, …) for
direct comparison between experiments.
Viruses. The following ZIKV strains were obtained through BEI Resources,
NIAID, NIH: Zika Virus, FLR, NR-50183 (ZIKVC) and ZIKV, H/PAN/2015/CDC-
259359, NR-50219 (ZIKVP). ZIKVC and ZIKVP were isolated in December 2015
from the blood of infected patients from Colombia and Panama, respectively. The
ZIKV strain PRVABC59, which was used as a control for immunohistochemistry
experiments, originated from a human serum specimen in December of 2015 in
Puerto Rico (NCBI Accession No. KU501215). ZIKVC and ZIKVP were grown on
Vero cells for 72 h. The cleared supernatant was stored at –80 °C and used for
infection experiments. To obtain concentrated virus, the ZIKV-containing super-
natant was passed through a 0.45-μm filter (Millipore) and ultracentrifugation was
performed at 30,000 g for 15 h by using a SW28 rotor (Beckman Coulter). In all
experiments, supernatants from noninfected Vero cells were used as noninfected
controls (mock). The multiplicity of infection (MOI) was calculated by virus
titration on Vero cells by using standard plaque assay to measure plaque-forming
units per mL of virus (PFUs/mL). All experiments involving infectious ZIKV were
performed in a BSL-3 facility. DENV2 strain 16681 was obtained from the Bio-
logical Resource Center of Institut Pasteur, France. Viral stocks were prepared on
C6/36 cells (provided by M. Flamand, Institut Pasteur, France). Virus titers were
assessed by focus-forming assays on Vero cells27. HIV-1 was obtained from the
supernatant of HEK 293T cells transfected with pNL(AD8)72.
Flow cytometry. To process the cells for flow cytometry analysis, the samples were
first blocked with 10% FBS in PBS. Human FcR Blocking Reagent (Miltenyi Biotec)
was added to prevent unspecific binding of IgGs to Fc receptors (FcR). To label cell
surface markers, samples were stained with a cocktail of primary-labeled antibodies
at 4 °C. To detect intracellular proteins, cells were fixed in 4% paraformaldehyde
(PFA) and permeabilized by using 0.1% Triton X-100 (Sigma) and 0.5% BSA
(Euromedex). PBMC samples were acquired with a 10-channel Navios flow cyt-
ometer (Beckman Coulter) with a combination of 405-, 488-, and 640-nm lasers.
The other samples were acquired with a LSR II flow cytometer (BD Biosciences), a
MACS Quant flow cytometer (Miltenyi Biotec), a Cytoflex flow cytometer (Beck-
man Coulter), or a Novocyte (ACEA Biosciences). All data were analyzed by using
FlowJo, LLC software version v10.4.2.
Antibodies. A list of the used antibodies with their dilutions can be found in
Supplementary Table 1. When necessary, some primary antibodies were labeled
with Alexa Fluor 488 or 647 by using an antibody labeling kit (Molecular Probes).
Reagents. ZCL278 was purchased from Tocris and diluted in DMSO at 50 mM.
ICAM-1 recombinant protein (#ADP4-050), and fibronectin isolated from human
plasma (1918-FN-02M) were purchased from R&D Systems. The type I solution of
rat collagen, Lucifer Yellow CH dilithium salt, Resveratrol, and Lithium Chloride
were purchased from Sigma-Merck. The recombinant human CCL2/MCP-1 Pro-
tein was obtained from R&D Systems and Miltenyi Biotec.
Human subjects. The human fetal brain tissues used in this study were obtained
from a PCR-confirmed case of congenital ZIKV with a gestational age of 22 weeks,
similar to cases that we previously described73. The fetal brain tissues were initially
submitted to CDC for diagnostic testing during the Zika response as part of the
routine pathology services provided by CDC to state and territorial authorities.
Both the initial receipt of human samples [061116SZ] and the secondary use
[102517GH] were submitted for review human subjects in accordance with stan-
dard NCEZID procedures, and both were determined to be outside the scope of
IRB review requirements under 45 CFR 46 [pre-2018 rule] by the NCEZID Senior
Human Subjects Advisor, as authorized by CDC institutional policy, as the fetuses
are not living individuals [46 CFR 46.102(d), pre-2018 rule].
Immunohistochemistry. Immunohistochemical assays were performed by using a
peroxidase and alkaline-phosphatase detection system. Briefly, 4-μm tissue sections
were placed on slides. The sections were deparaffinized in xylene and rehydrated
through graded alcohol solutions. Colorimetric detection of antibodies was per-
formed by using the EnVision G|2 Doublestain System Rabbit/Mouse (DAB
+ /Permanent Red) (Agilent). Heat-induced epitope retrieval (HIER) by using
EDTA-based buffer was performed (Biocare Medical) using the Biocare NxGen
decloaker program #5 (110 °C for 15 min). All slides were then treated according to
the Dako EnVision G|2 Doublestain System procedure. Slides were incubated in
Endogenous Enzyme block for 5 min, primary antibody for 10 min, HRP-Polymer
for 10 min, and DAB working solution for 10 min. Doublestain block was then
applied for 3 min, and the second stain procedure consisted of the other primary
antibody for 10 min, followed by the Rabbit/Mouse Link, AP-Polymer, and Per-
manent Red working solution for 10 min each. Slides were double stained with a
ZIKV-specific anti-NS1 monoclonal antibody (clone 3C2) and one of the following
markers: CD68, CD163, CD14, or CD45. In each double stain, CD markers and
ZIKV were each labeled with Permanent Red and DAB in serial sections.
Appropriate negative control serum was run in parallel. Slides were counterstained
in Mayer’s Hematoxylin (Polyscientific) and blued in Lithium carbonate (Poly-
sciences). Slides were coverslipped with aqueous mounting medium (Polysciences).
All steps of the staining procedure, with the exception of the HIER, were performed
at room temperature.
Human cortical organoids. Cortical organoids were generated from H9 human
embryonic stem cells (hESCs; female, WA09, WiCell)31. Briefly, H9 hESCs were
grown on mitomycin-C-treated MEF feeding layers in ESC culture medium:
DMEM/F12+ L-glutamine (Thermofisher) with 20% KnockOut serum replace-
ment (Thermofisher), 1× non-essential amino acids (Thermofisher), 100 μM β-
mercaptoethanol (Thermofisher), and 1× Penicilin–Streptomycin (Thermofisher).
The hESC culture medium was changed daily and freshly supplemented with 8 ng/
ml human bFGF (Sigma). For organoid differentiation, the culture medium was
replaced with differentiation medium: ESC culture medium with 1× Sodium
Pyruvate (Thermofisher) but without addition of human bFGF. Colonies of ~2 mm
in diameter were manually lifted by using a Corning cell lifter and were transferred
to a 60-mm ultra-low attachment dish (Corning). After 24 h (day 0), embryoid
bodies had formed and half of the medium was replaced with differentiation
medium supplemented with 3 μM IWR-1-Endo (Sigma), 1 μM Dorsomorphin
(Sigma), 10 μM SB-431542 (Sigma), and 1 μM Cyclopamine (Sigma). The medium
was replaced every other day until the harvest. From day 3 onward, 60-mm dishes
with organoids were placed on a belly-button shaker in the incubator. From day 18
onward, organoids were cultured in Neurobasal medium (Thermofisher) with 1×
N2 supplement (Thermofisher), 2 mM L-glutamine, 1× pen–strep, and 1 μM
Cyclopamine. From day 24 onward, Cyclopamine was not added anymore.
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Cerebral organoids were cocultured with ZIKV-infected monocytes,
noninfected monocytes, cell-free ZIKV, or mock for either 2 or 9 days. The media
was replaced every other day. At the indicated time points, the organoids were
processed for flow cytometry or immunofluorescence. For the flow cytometry
analysis, the organoids were dissociated with trypsin, stained with Viobility 405/
502 (Miltenyi), fixed with 4% PFA for 20 min at RT, and permeabilized and stained
with anti-CTIP2, Pax6, CCR2, and 4G2 antibodies. For immunofluorescence, the
monocytes were prelabeled with CellTrace Violet (Invitrogen) before addition to
the organoids. The cerebral organoids were then fixed with 4% PFA for 1 h at RT,
permeabilized with 1% Triton X-100 (2 days at RT), and labeled with anti-CTIP2,
Pax6, and 4G2 antibodies (1 day at RT), and then with fluorescent secondary
antibodies and Dapi (1 day at RT). They were clarified overnight at RT by using
RapiClear 1.52 reagent (Sunjin Lab). The clarification was observed to be important
to perform in-depth whole-organoid imaging, as the clarification medium
homogenizes the refractive index of the organoid and diminishes scattering of the
emitted photons. All stainings were done in the presence of human FcR-blocking
reagent. Image acquisition was performed on a spinning-disk confocal microscope
(Dragonfly, Oxford Instruments) equipped with an ultrasensitive 1024 × 1024
EMCCD camera (iXon Life 888, Andor) and four laser lines (405, 488, 561, and
637 nm). A 20×, NA 0.8 air objective was used for whole-organoid imaging and a
40×, NA 1.15 (Nikon) water-immersion long-distance (0.6 mm) objective was used
for in-depth imaging of selected areas of the organoid. For the z-stacks a z step of
1 μm was used. Images were processed by using Imaris ×64 (Bitplane) version 9.2.
Organotypic cultures of mouse cerebellar slices. Organotypic cerebellar slices
were prepared from P10–P12 CD1 mice74. This study was carried out in strict
accordance with the national and European community guidelines for laboratory
animal welfare and experimentation. All experiments were approved in advance by
the Ethics Committee of Strasbourg, France (CREMEAS, CEEA35). Mice were bred
and housed in a 12-h light/dark cycle with free access to food and water. After
decapitation, the cerebellum was dissected out in minimum essential medium
(MEM) with 25 mM HEPES, 4 g/L D-Glucose, 50 UI/mL penicillin, and 50 μg/mL
streptomycin. Isolated cerebella were cut into 350 -μm parasagittal slices by using a
McIlwain tissue chopper (MickleLab). Slices were transferred onto 30-mm culture
inserts with 0.4-μm pore size (Millicell, Merck Millipore). Inserts were placed in
six-well plates containing 1 mL of culture medium per well. Culture medium was
composed of 50% MEM with 25 mM HEPES, 25% Basal Medium Eagle, and 25%
heat-inactivated horse serum supplemented with 2.10−3M GlutaMAX, 50 UI/mL
penicillin, 50 μg/mL streptomycin, and 4 g/L D-glucose. The slices were incubated
at 37 °C in a humidified incubator equilibrated with 95% air/5% CO2. The medium
was refreshed every 2 days. D-Glucose, penicillin, and streptomycin were from
Sigma-Aldrich. Culture media, horse serum, and GlutaMAX were from Thermo
Fisher.
One week after culture, the slices were treated with 106 monocytes (ZIKV-
infected or not) per slice. The cell-free virus condition was performed by using 106
PFUs of ZIKV, corresponding to the amount used to infect monocytes at a MOI of
1. Monocytes and virus preparations were applied dropwise to the top (air
interface) of each slice.
Individual organotypic cerebellar slices were fixed by using 4% PFA in
phosphate buffer solution (PBS) for 30 min at room temperature. Then, the slices
were transferred to a saturation solution containing PBS with 0.2% Triton, 2%
bovine serum albumin (Sigma-Aldrich), and 10% goat serum (Merk Millipore) for
a minimum of 12 h. Purkinje cells were specifically labeled by using an anti-
calbindin antibody. The secondary antibody was an Alexa-488 donkey anti-mouse.
Primary and secondary antibodies dilutions were prepared in PBS supplemented
with 0.2% Triton, 2% bovine serum albumin (BSA), and 5% normal goat serum
(Merck Millipore), and labeling at each step was performed for a minimum of 24 h
at 4 °C. Slices were mounted on glass coverslips with Prolong Gold antifade reagent
(Invitrogen). Confocal images were produced at the imaging facility service of the
Neuropole (CNRS, UPS 3156, Strasbourg, France) by using a Leica SP5II inverted
confocal microscope (10×, 20×, or 63× objectives). Fields were acquired by using a
488-nm argon laser and a 561-nm diode-pumped solid-state laser.
ZIKV RNA detection by FISH. Cells were attached on #1.5 glass coverslips by
using Poly-L-lysin, and FISH was performed by using the QuantiGene ViewRNA
ISH Assay Kit following the manufacturer’s instruction (Affymetrix) and a specific
probe recognizing ZIKV plus strand RNA (Affymetrix VF1-19981). Cell DNA was
stained with NucBlue (Thermo Fisher). Images were acquired with an inverted
confocal microscope (Zeiss LSM 700) and processed with Zen2 (blue edition)
software (Zeiss).
RT-qPCR. Total RNA was extracted from monocytes with the NucleoSpin RNA II
kit (Macherey-Nagel). First-strand complementary DNA synthesis was performed
with the SuperScript III First-Strand Synthesis System Reverse Transcriptase
(Invitrogen). Quantitative real-time PCR was performed on a real-time PCR sys-
tem (ABI PRISM 7900HT) with SYBR Green PCR Master Mix (Life Technologies).
Data were analyzed with the 2-DDCT method75, with all samples normalized to
GAPDH. The ZIKV forward and reverse primers used were 5′-AARTACACATAC
CARAACAAAGTGGT-3′ and 5′-TCCRCTCCCYCTYTGGTCTTG-3′76. The
GAPDH forward and reverse primers used were 5′-GGTCGGAGTCAACGGATT
TG-3′ and 5′- ACTCCACGACGTACTCAGCG-3′. The CD99 forward and reverse
primers used were 5′-CTCTTCCCCTTCTTTCCTGTG-3′ and 5′-CAAATCCAAA
CCCCAACCAC-3′. The ITGAL forward and reverse primers used were 5′- TCAT
ACACCACGTCAACCTTC-3′ and 5′-CTCTTCCATGTTCAGCCTCTG-3′.
Transmigration assay. The hCMEC/D3 cells were seeded at a density of
40–50,000 cells/cm² in hanging cell culture inserts (PET, 5-μm pores, Millipore)
pre-coated with rat collagen type 1 (Sigma). The cells were kept in culture for
7 days until ready for the transmigration and permeability assays. Infected
monocytes were extensively washed in RPMI 2% FBS media before addition to the
transwell inserts containing the hCMEC/D3 cells. In parallel, the media in the
bottom chamber was replaced with fresh media containing 200 ng/mL of MCP-1
(Miltenyi Biotech). Transmigration was allowed to occur overnight (about 17 h).
Monocytes were recovered from the top and bottom chambers of the insert and
prepared for flow cytometry analysis.
Lucifer yellow permeability assay. On day 7 of culture of hCMEC/D3 cells in the
transwell, permeability was assessed by adding 50 μM Lucifer yellow in the top
chamber. After 120 min at 37 °C, media was collected from the top and bottom
chambers of the insert. In parallel, a calibration curve of Lucifer yellow was pre-
pared (50, 25, 12.5, and 6.25 μM). Quantification of fluorescence was done by using
a microplate reader (Mithras LB 940 Multimode Microplate Reader, Berthold
Technologies) with excitation at 488 nm and emission filter at 520 nm. The per-
meability coefficient (Pc) was calculated as described in ref. 35.
Cell viability. Cell viability was assessed by using the Pierce LDH Cytotoxicity
Assay Kit (Thermofisher Scientific) according to the manufacturer’s instructions.
Absorbance was measured with a Mithras LB 940 Multimode Microplate Reader
(Berthold Technologies).
Immunofluorescence. ZIKV-infected monocytes cocultured with either hCMEC/
D3 cells or hNPCs grown on coverslips were fixed with 4% PFA, permeabilized
with 0.1% Triton X-100 and 0.5% BSA, and labeled with primary antibodies and
fluorescent secondary antibodies as necessary. The staining was done in the pre-
sence of human FcR-blocking reagent and nuclei were labeled with Dapi. Cover-
slips were mounted on slides by using Fluoromount Aqueous Mounting (Sigma).
Image acquisition was performed on an AxioObserver.Z1 inverted microscope
(Zeiss) mounted with a spinning-disc head (Yokogawa), a back-illuminated
EMCCD camera (Evolve, Photometrics), and a ×63 or ×100, 1.45 NA oil objective
(Zeiss). Images were processed by using FiJi (ImageJ software version 1.51 h) and
the 3D reconstruction was performed by using Imaris ×64 version 9.2.
Adhesion assay. Adhesion assays were performed either in plastic 96-well plates
(flat bottom) or on glass coverslips. The coating of the substrate was done with 150
μg/mL of collagen, type I solution from rat tail (Sigma), 12.5 μg/mL of recombinant
Human ICAM-1/CD54 (R&D Systems), or 5 μg/cm2 of human fibronectin from
R&D Systems. Primary monocytes were added to the coated substrate and incu-
bated for 2 h at 37 °C. Afterward, the cells were processed for immunofluorescence
staining with Phalloidin A568 (Invitrogen), or analyzed for cell viability with the
CellTiter-Glo Luminescent Cell Viability Assay (Promega).
Scanning electron microscopy. ZIKV-infected monocytes cocultured with
hCMEC/D3 cells on coverslips were washed twice with Cacodylate buffer (pre-
warmed), and fixed with 2.5% glutaraldehyde for 1 h at RT. The samples were
dehydrated in a graded alcohol series, coated with platinum, and imaged with a
Phenom ProX Desktop scanning electron microscope (Thermo Fisher).
Quantitative proteomics. The protein concentration of all samples was deter-
mined by using the RC-DC protein assay (Bio-Rad) according to the manu-
facturer’s instructions and a standard curve was established by using BSA. Five
micrograms of protein lysate for each sample and a sample pool for quality control
(QC) were heated at 95 °C for 5 min and concentrated on a stacking gel band. The
gel bands were cut, washed with ammonium hydrogen carbonate and acetonitrile,
reduced, and alkylated before trypsin digestion (Promega). The generated peptides
were extracted with 60% acetonitrile in 0.1% formic acid followed by a second
extraction with 100% acetonitrile. Acetonitrile was evaporated under vacuum and
the peptides were resuspended in 10 μL of H2O and 0.1% formic acid before
nanoLC–MS/MS analysis.
NanoLC–MS/MS analyses were performed on a nanoACQUITY Ultra-
Performance LC system (Waters, Milford, MA) coupled to a Q-Exactive Plus
Orbitrap mass spectrometer (ThermoFisher Scientific) equipped with a
nanoelectrospray ion source. The solvent system consisted of 0.1% formic acid in
water (solvent A) and 0.1% formic acid in acetonitrile (solvent B). Samples were
loaded into a Symmetry C18 precolumn (0.18 × 20 mm, 5-μm particle size; Waters)
over 3 min in 1% solvent B at a flow rate of 5 μL/min followed by reverse-phase
separation (ACQUITY UPLC BEH130 C18, 200 mm × 75 μm id, 1.7-μm particle
size, Waters) by using a linear gradient ranging from 1 to 35% of solvent B at a flow
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rate of 450 nL/min. The mass spectrometer was operated in data-dependent
acquisition mode by automatically switching between full MS and consecutive MS/
MS acquisitions. Survey full-scan MS spectra (mass range 300–1800) were acquired
in the Orbitrap at a resolution of 70 K at 200 m/z with an automatic gain control
(AGC) fixed at 3.106 and a maximal injection time set to 50 ms. The ten most
intense peptide ions in each survey scan with a charge state  2 were selected for
fragmentation. MS/MS spectra were acquired at a resolution of 17.5 K at 200 m/z,
with a fixed first mass at 100 m/z, AGC was set to 1.105, and the maximal injection
time was set to 100 ms. Peptides were fragmented by higher-energy collisional
dissociation with a normalized collision energy set to 27. Peaks selected for
fragmentation were automatically included in a dynamic exclusion list for 60 s. All
samples were injected by using a randomized and blocked injection sequence (one
biological replicate of each group plus pool in each block). To minimize carryover,
a solvent blank injection was performed after each sample. A sample pool
comprising equal amounts of all protein extracts was constituted and regularly
injected four times during the course of the experiment, as an additional QC.
Protein identification rates and coefficient of variation (CV) monitoring of this QC
sample revealed very good stability of the system: 2597 of the 2805 identified
proteins, namely 92%, showed a CV value lower than 25% considering all four
injections.
Raw MS data processing was performed by using MaxQuant software77
v1.6.0.16. Peak lists were searched against a database including Homo sapiens
protein sequences extracted from SwissProt (06-03-2019; 20 410 sequences,
Taxonomy ID 9606) using the MSDA software suite78.
MaxQuant parameters were set as follows: MS tolerance set to 20 ppm for the
first search and 5 ppm for the main search, MS/MS tolerance set to 40 ppm,
maximum number of missed cleavages set to 1, Carbamidomethyl (C) set as fixed
modification, and Oxidation (M) set as variable modification. False-discovery rates
(FDRs) were estimated based on the number of hits after searching a reverse
database and were set to 1% for both peptide spectrum matches (with a minimum
length of seven amino acids) and proteins. Data normalization and protein
quantification was performed by using the LFQ (label-free quantification) option
implemented in MaxQuant by using a “minimal ratio count” of 1. The Match
between runs option was enabled by using a 2-min time window after retention-
time alignment. All other MaxQuant parameters were set as default. To be
considered, proteins must be identified in all four replicates of at least one
condition and a minimum of two unique peptides. The imputation of the missing
values and differential data analysis was performed by using the open-source
ProStaR software79. Two runs of imputation were applied, the SLSA mode was
applied for the partially observed values and the det quantile for the missing in the
entire condition80. A Limma-moderated t-test was applied on the dataset to
perform differential analysis. The adaptive Benjamini–Hochberg procedure was
applied to adjust the p values and FDR values under 1 or 5% depending on the
comparisons were achieved. Data analyses were performed by using the STRING
online tool36, by using the highest confidence (0.9 interaction score). The unlinked
proteins were excluded from the network shown in Fig. 5a. The same data were
also processed by using the GSEA online tool37, using features from gene ontology
“biological process” and “cellular component”.
Antibody-dependent enhancement assay. For virus–antibody complex forma-
tion, virus particles (MOI 5) were incubated for 30 min at 37 °C in the presence of
serial tenfold dilutions of the 4G2 antibody in RPMI medium containing 2% FBS.
The virus–antibody complexes were then added to primary monocytes and incu-
bated at 37 °C with 5% CO2. At 48 hpi, the cells were thoroughly washed, fixed, and
processed for flow cytometry analysis as described below.
Zebrafish experiments. All animal procedures were performed in accordance
with French and European Union animal welfare guidelines and all experiments
were approved in advance by the Ethics Committee of Strasbourg (CREMEAS,
CEEA35). Tg(fli1a:eGFP) zebrafish (Danio rerio) embryos (ZFIN ID: ZDB-FISH-
150901-3654) were used in all experiments. Embryos were maintained in Danieau
0.3X medium (17.4 mM NaCl, 0.2 mM KCl, 0.1 mM MgSO4, and 0.2 mM Ca
(NO3)2) buffered with 0.15 mM HEPES (pH= 7.6) and supplemented with
200 mM of 1-Phenyl-2-thiourea (Sigma-Aldrich). For all zebrafish experiments, the
offspring of one single cross was selected, based on anatomical/developmental good
health. Embryos were split randomly between experimental groups. Forty-eight
hours post fertilization (hpf), embryos were mounted in a 0.8% low-melting-point
agarose pad containing 650 mM of tricain (ethyl-3-aminobenzoate-methanesulfo-
nate) to immobilize them. Pre-labeled primary human CD14+ monocytes were
injected with a Nanoject microinjector 2 (Drummond) and microforged glass
capillaries (20-μm inner diameter) filled with mineral oil (Sigma), and 14 nL of a
cell suspension at 108 cells per mL were injected in the duct of Cuvier of the
embryos under the M205 FA stereomicroscope (Leica)41. At 5–7 h post injection,
confocal imaging was performed with an inverted TCS SP5 confocal microscope
with a HC PL IRAPO 20× NA 0.75 objective (Leica). The experiment was carried
out three independent times by using three different monocyte donors with n= 10
embryos per condition (exception: n= 5 for the second donor, condition
ADE–ZIKV). The monocytes were labeled with CellTrace Yellow (Invitrogen)
according to the manufacturer’s instructions.
For live recording of the injection, a stereomicroscope with a DFC3000 G
camera (Leica) was used. To capture flowing and arresting monocytes in real time,
only the red channel (corresponding to injected prelabeled monocytes) was
recorded during injection. After 5 min, a single image of the zebrafish vasculature
was acquired and used as an overlay background for the registered time-lapse
recording of monocytes.
Cell dispersion was manually counted and localized in the caudal plexus by
using the stereotype patterning of intersegmental vessels (ISVs) as a reference. The
data were compiled to generate heatmaps by using a custom-made MATLAB
plugin41. Post processing was performed by using ImageJ and Imaris ×64 version
9.2 for segmentation, 3D reconstruction, and tracking.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
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